Since our inception in 2004, our steadfast focus has been providing research grants to the worlds’ leading scientists researching Alzheimer’s disease. We are honored to work with scientists who are passionate in their pursuit to rid our world of this debilitating disease.

Many of the funded projects have resulted in significant breakthroughs in developing a better understanding of Alzheimer’s disease and getting closer to a cure.

Robert Moir | 2017

Chronic Viral Neuroinfection Mediates Amyloid Beta Deposition in Transgenic Alzheimer’s Disease Mice

Jacob M. Hooker, PH.D | 2018

Neuroimmune Molecular Imaging: Redefining the Landscape of Opportunities in Alzheimer’s Disease

Meng Chen, Ph.D., Rudy Tanzi | 2018

The Role of Neurexins in Alzheimer’s Disease (Year 2)

Berislav Zlokovic | 2018

PICALM Gene Therapy and Drug Screening for Amyloid Beta Clearance (Year 3)

Tony Wyss-Coray | 2018

Rejuvenation of Microglia in Brain Aging and Neurodegeneration (Year 3)

Beth Stevens | 2018

Microglial Heterogeneity and Transcriptional State Changes in Alzheimer’s Disease

Christopher K. Glass, M.D., PH.D. | 2018

Interpretation of Noncoding Risk Alleles for Alzheimer’s Disease

Marc Diamond | 2016

Genetic Targets to Block Tau Propagation: Test Knockdown of HSPG Genes in Vivo

Randall Bateman | 2017

Stable Isotope Labeling and Quantitative Mass Spectrometry Imaging of Alzheimer’s Disease Pathology in Human Brain

Benjamin Wolozin | 2017

Inhibition of Tau Pathology in Human Neurons

David Holtzman | 2017

Understanding the Effect of APOE on Tau-Mediated Neurodegeneration

Guojun Bu | 2017

Effects of Peripheral APOE on Central Nervous System Functions and AD Pathogenesis

Funded Projects

The science that has advanced our understanding of Alzheimer's disease